Who Paid My Doc
Andrew Hudnut
Family Medicine Elk Grove, CA
NPI 1104928852 CMS profile 1220493
8170 Laguna Blvd, #220, Elk Grove, CA 95758
General payments
$0
Research payments
$0
Ownership & investment interest
$0
The CMS Open Payments record contains no reported payments to Andrew Hudnut of Elk Grove, CA.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
Prescribing to Medicare patients
Part D · data year 2024 · 104 drugsPart D claims
4,778
Drug cost
$1,231,225
Branded share of claims
19.8%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Daybue Trofinetide | Brand | 11 | $911,271 | |
| Trulicity Dulaglutide | Brand | 43 | $75,404 | |
| Eliquis Apixaban | Brand | 76 | $75,208 | |
| Rybelsus Semaglutide | Brand | 16 | $37,808 | |
| Spiriva Respimat Tiotropium Bromide | Brand | 16 | $12,292 | |
| Advair Hfa Fluticasone Propion/Salmeterol | Brand | 21 | $11,401 | |
| Combivent Respimat Ipratropium/Albuterol Sulfate | Brand | 19 | $9,885 | |
| Wixela Inhub Fluticasone Propion/Salmeterol | Brand | 47 | $7,111 | |
| Qvar Redihaler Beclomethasone Dipropionate | Brand | 19 | $5,567 | |
| Famotidine | Generic | 167 | $5,324 |
The 10 drugs with the highest cost, of 104 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 25 billing codesPaid by Medicare
$33,010
Medicare patients
152
Services billed
429
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 63% | |
| Arthritis | 38% | |
| Diabetes | 31% | |
| Chronic kidney disease | 30% | |
| Ischemic heart disease | 20% | |
| Heart failure | 17% | |
| COPD | 16% | |
| Depression | 16% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Vaccine for influenza for injection into muscle 90653 | Office | 18 | 18 | $1,473 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Other Family Medicine in California
Related records
Family Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Family Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.